|

Droxidopa capsules Clinical Trials

1 actively recruiting trial across 1 location

Also known as: L-threo-3,4-dihydroxyphenylserine

Pipeline

Phase 2: 1

Top Sponsors

  • Giuseppe Cullaro, MD1

Indications

  • Decompensated Cirrhosis of Liver1
  • Liver Disease1
  • Acute Kidney Injury1
  • Cirrhosis1

New York, New York1 trial

Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury

Columbia University Irving Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.